Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia

Completed · Phase 4

Conditions studied: Primary Dyslipidemia, Mixed Dyslipidemia

In brief

Randomized, double-blind, double-dummy, 12-week, active-controlled study of pitavastatin 4 mg daily(QD) vs. pravastatin 40 mg daily(QD) in subjects with primary hyperlipidemia or mixed dyslipidemia.

Key facts

Study ID

NCT01256476

Run by

Kowa Research Institute, Inc.

People needed

328

Starts

2010-10-01

Expected to finish

2011-06-01

Last updated by the study team

2012-05-08

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female subjects with primary hypercholesterolemia or mixed dyslipidemia who are ≥18 and ≤80 years of age at the time of consent
• Plasma Low-density lipoprotein cholesterol (LDL-C) ≥130 milligrams per deciliter (mg/dL) and ≤220 mg/dL and triglyceride (TG) levels of ≤400 mg/dL

You may not qualify if…

• Homozygous familial hypercholesterolemia
• Any conditions which may cause secondary dyslipidemia
• Uncontrolled diabetes mellitus

Where it is running

• Study site — Huntsville, Alabama, United States
• Study site — Muscle Shoals, Alabama, United States
• Study site — Chandler, Arizona, United States
• Study site — Goodyear, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Beverly Hills, California, United States
• Study site — Los Angeles, California, United States
• Study site — Newport Beach, California, United States
• Study site — Colorado Springs, Colorado, United States
• Study site — Clearwater, Florida, United States
• Study site — DeLand, Florida, United States
• Study site — Fort Luaderdale, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Oviedo, Florida, United States
• Study site — Pembroke Pines, Florida, United States
• Study site — Ponte Vedra, Florida, United States
• Study site — Addison, Illinois, United States
• Study site — Chicago, Illinois, United States
• Study site — Evansville, Indiana, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Kansas City, Kansas, United States
• Study site — Erlanger, Kentucky, United States
• Study site — Baltimore, Maryland, United States
• Study site — Brockton, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.